City
Epaper

50 pc tariffs by US bad policy move, India must continue to protect its farmers: SBI report

By IANS | Updated: August 8, 2025 10:44 IST

New Delhi, Aug 8 Imposition of 25 per cent penalty on goods trade with India, with a proposition ...

Open in App

New Delhi, Aug 8 Imposition of 25 per cent penalty on goods trade with India, with a proposition of additional 25 per cent on the world’s largest democracy, can be a bad policy decision for the US and its people, an SBI Research report said on Friday.

On the other hand, India — strategically protecting its sovereignty — must continue to protect its farmers from likelihood of predatory practices of select global conglomerates who may vie for a lucrative ‘Desi’ pie without investing in sustainable market infrastructure creation, anchoring agri value chain financing and being a partner in welfare schemes that upend ‘Ease of Living’ for our farming community, the report stressed.

Significantly, India has trumped global giants in milk production between 2015-2024.

In the year 2015, India's total milk production stood close to 155.5 million tonnes (EU 154.6 MT and US 94.6 MT).

When it comes to the pharmaceuticals market, India has been a cornerstone of the global supply chain for affordable, high-quality, essential medicines, particularly life saving oncology drugs, antibiotics, and chronic diseases' treatments.

“In the generic drug market, India supplies nearly 35 per cent of the pharmaceutical needs of the US. If the US shifts manufacturing and API production to other countries or domestic facilities, it will take minimum 3-5 years for meaningful capacity,” said the report.

In the US, health expenditure per person per annum is around $15,000, and hence with 35 per cent, India’s share in generic drugs tariff is going to impact US citizens significantly.

“Putting tariff on India pharma exports hurts the US objective of reducing the size of general government and goes against the objectives of DOGE. The US national health expenditures is 17.6 per cent of the GDP and the government-sponsored Medicare and Medicaid account for 36 per cent of the total expenditure,” said the report, adding that higher price of affordable medicines increase both expenditure under Medicare and Medicaid and also the out-of-pocket expenditure of private citizens.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentNeeraj Pandey talks about battling adverse weather challenges during ‘Special Ops 2’ shoot

NationalDemocracy under threat, says former Rajasthan CM Gehlot; accuses EC of bias

LifestyleGanpati Home Decoration Ideas 2025: Easy and Eco-friendly Makhar Ideas For Ganeshotsav

InternationalSouth Korea: Govt discussing joint Seoul-Washington measures to build peace with North Korea

BusinessOakridge Grade 10 Students Achieve outstanding MYP Results

National Realted Stories

NationalSC rejects CBI plea to review its decision against piecemeal charge sheets

HealthRaksha Bandhan: How to Tell if Shop Sweets Are Real or Fake in Just One Minute?

NationalED’s charge sheet against Bengal Minister mentions Rs 1.5 crore transaction

NationalTwo CRPF jawans injured in Maoist IED blast in Jharkhand’s Chaibasa, airlifted to Ranchi

NationalRs 50 lakh to 1 crore homes dominate from 2022–2024, budget homes demand declines